Medpace (MEDP) PT Lowered to $199 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts MEDP Hot Sheet
Price: $692.68 --0%
Rating Summary:
4 Buy, 16 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 15 | New: 8
Rating Summary:
4 Buy, 16 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 15 | New: 8
Join SI Premium – FREE
Baird analyst Eric Coldwell lowered the price target on Medpace (NASDAQ: MEDP) to $199.00 (from $233.00) while maintaining a Neutral rating.
You May Also Be Interested In
- BofA Securities Double Downgrades Sprouts Farmers Market (SFM) to Underperform
- Boss Energy Ltd (BOE:AU) PT Raised to AUD2.10 at Canaccord
- Woolworths Group Ltd (WOW:AU) PT Lowered to AUD39.50 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
